| Year |
Citation |
Score |
| 2022 |
Roe MK, Perez MA, Hsiao HM, Lapp SA, Sun HY, Jadhao S, Young AR, Batista YS, Reed RC, Taz A, Piantadosi A, Chen X, Liang B, Koval M, Snider TA, ... Moore ML, et al. An RSV live-attenuated vaccine candidate lacking G protein mucin domains is attenuated, immunogenic, and effective in preventing RSV in BALB/c mice. The Journal of Infectious Diseases. PMID 36281651 DOI: 10.1093/infdis/jiac382 |
0.322 |
|
| 2022 |
Tioni MF, Jordan R, Pena AS, Garg A, Wu D, Phan SI, Weiss CM, Cheng X, Greenhouse J, Orekov T, Valentin D, Kar S, Pessaint L, Andersen H, Stobart CC, ... ... Moore ML, et al. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2. Npj Vaccines. 7: 85. PMID 35906244 DOI: 10.1038/s41541-022-00509-6 |
0.346 |
|
| 2020 |
Human S, Hotard AL, Rostad CA, Lee S, McCormick L, Larkin EK, Peret TCT, Jorba J, Lanzone J, Gebretsadik T, Williams JV, Bloodworth M, Stier M, Carroll K, Peebles RS, ... ... Moore ML, et al. A respiratory syncytial virus attachment (G) gene variant associated with more severe disease in infants decreases fusion (F) protein expression which may facilitate immune evasion. Journal of Virology. PMID 33115881 DOI: 10.1128/JVI.01201-20 |
0.302 |
|
| 2020 |
Frey SJ, Varner C, Arsiwala A, Currier MG, Moore ML, Kane RS. The Design of Vaccines Based on the Shielding of Antigenic Site Ø of a Respiratory Syncytial Virus Fusion Protein Immunogen. Advanced Healthcare Materials. e2000714. PMID 32755047 DOI: 10.1002/Adhm.202000714 |
0.422 |
|
| 2019 |
Kwon YM, Lee Y, Kim KH, Jung YJ, Li Z, Jeeva S, Lee S, Moore ML, Kang SM. Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles. Vaccine. PMID 31542260 DOI: 10.1016/J.Vaccine.2019.09.041 |
0.393 |
|
| 2019 |
Kwon YM, Hwang HS, Lee YT, Kim KH, Lee Y, Kim MC, Lee YN, Quan FS, Moore ML, Kang SM. Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform. Immune Network. 19: e18. PMID 31281715 DOI: 10.4110/In.2019.19.E18 |
0.478 |
|
| 2019 |
DeFord DM, Nosek JM, Castiglia KR, Hasik EF, Franke ME, Nick BC, Abdelnour AM, Haas CE, Junod NA, Latsko KN, Moore ML, Berthrong ST, Rostad CA, Stobart CC. Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design. The Journal of General Virology. PMID 31184573 DOI: 10.1099/Jgv.0.001287 |
0.459 |
|
| 2018 |
Turi KN, Romick-Rosendale L, Gebretsadik T, Watanabe M, Brunwasser S, Anderson LJ, Moore ML, Larkin EK, Peebles RS, Hartert TV. Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing. Metabolomics : Official Journal of the Metabolomic Society. 14: 135. PMID 30830453 DOI: 10.1007/S11306-018-1431-Z |
0.453 |
|
| 2018 |
Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS, ... ... Moore ML, et al. The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography. Viruses. 10. PMID 30127286 DOI: 10.3390/V10080446 |
0.434 |
|
| 2018 |
Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, Ganti K, Cox RM, Sticher ZM, Edpuganti V, Mitchell DG, Lockwood MA, Kolykhalov AA, Greninger AL, Moore ML, et al. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses. Antimicrobial Agents and Chemotherapy. PMID 29891600 DOI: 10.1128/Aac.00766-18 |
0.431 |
|
| 2018 |
Turi KN, Shankar J, Anderson LJ, Rajan D, Gaston K, Gebretsadik T, Das SR, Stone C, Larkin EK, Rosas-Salazar C, Brunwasser SM, Moore ML, Peebles RS, Hartert TV. Infant Viral Respiratory Infection Nasal-Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze. American Journal of Respiratory and Critical Care Medicine. PMID 29733679 DOI: 10.1164/Rccm.201711-2348Oc |
0.407 |
|
| 2018 |
Bloodworth MH, Rusznak M, Pfister CC, Zhang J, Bastarache L, Calvillo SA, Chappell JD, Boyd KL, Toki S, Newcomb DC, Stier MT, Zhou W, Goleniewska K, Moore ML, Hartert TV, et al. Glucagon-like peptide-1 receptor signaling attenuates RSV-induced type 2 responses and immunopathology. The Journal of Allergy and Clinical Immunology. PMID 29678751 DOI: 10.1016/J.Jaci.2018.01.053 |
0.378 |
|
| 2018 |
Mousa JJ, Binshtein E, Human S, Fong RH, Alvarado G, Doranz BJ, Moore ML, Ohi MD, Crowe JE. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins. Plos Pathogens. 14: e1006837. PMID 29470533 DOI: 10.1371/Journal.Ppat.1006837 |
0.353 |
|
| 2018 |
Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK, Gebretsadik T, Halpin RA, Nelson KE, Moore ML, Anderson LJ, Peebles RS, Das SR, Hartert TV. Nasopharyngeal Lactobacillus is Associated with Childhood Wheezing Illnesses Following Acute Respiratory Syncytial Virus Infection in Infancy. The Journal of Allergy and Clinical Immunology. PMID 29330010 DOI: 10.1016/J.Jaci.2017.10.049 |
0.435 |
|
| 2017 |
Rostad CA, Stobart CC, Todd SO, Molina SA, Lee S, Blanco JCG, Moore ML. ENHANCING THE THERMOSTABILITY AND IMMUNOGENICITY OF AN RSV LIVE-ATTENUATED VACCINE BY INCORPORATING UNIQUE RSV LINE19F PROTEIN RESIDUES. Journal of Virology. PMID 29263264 DOI: 10.1128/Jvi.01568-17 |
0.441 |
|
| 2017 |
Stobart CC, Nosek JM, Moore ML. Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine. Frontiers in Microbiology. 8: 2412. PMID 29259600 DOI: 10.3389/Fmicb.2017.02412 |
0.381 |
|
| 2017 |
Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, et al. Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nature Communications. 8: 1877. PMID 29187732 DOI: 10.1038/S41467-017-01858-W |
0.417 |
|
| 2017 |
Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, et al. Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nature Communications. 8: 1877. PMID 29187732 DOI: 10.1038/s41467-017-01858-w |
0.308 |
|
| 2017 |
Chatterjee S, Luthra P, Esaulova E, Agapov E, Yen BC, Borek DM, Edwards MR, Mittal A, Jordan DS, Ramanan P, Moore ML, Pappu RV, Holtzman MJ, Artyomov MN, Basler CF, et al. Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses. Nature Microbiology. 2: 17101. PMID 28665409 DOI: 10.1038/Nmicrobiol.2017.101 |
0.397 |
|
| 2017 |
Stier MT, Goleniewska K, Cephus JY, Newcomb DC, Sherrill TP, Boyd KL, Bloodworth MH, Moore ML, Chen K, Kolls JK, Peebles RS. STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 28576981 DOI: 10.4049/Jimmunol.1601984 |
0.409 |
|
| 2017 |
Stobart CC, Hotard AL, Meng J, Moore ML. BAC-Based Recovery of Recombinant Respiratory Syncytial Virus (RSV). Methods in Molecular Biology (Clifton, N.J.). 1602: 111-124. PMID 28508217 DOI: 10.1007/978-1-4939-6964-7_8 |
0.485 |
|
| 2017 |
Leemans A, De Schryver M, Van der Gucht W, Heykers A, Pintelon I, Hotard AL, Moore ML, Melero JA, McLellan JS, Graham BS, Broadbent L, Power UF, Caljon G, Cos P, Maes L, et al. Antibody-induced internalization of the human respiratory syncytial virus fusion protein. Journal of Virology. PMID 28468888 DOI: 10.1128/Jvi.00184-17 |
0.467 |
|
| 2017 |
Achten NB, Wu P, Bont L, Blanken MO, Gebretsadik T, Chappell JD, Wang L, Yu C, Larkin EK, Carroll KN, Anderson LJ, Moore ML, Sloan CD, Hartert TV. Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy. The Journal of Infectious Diseases. PMID 28368456 DOI: 10.1093/Infdis/Jix031 |
0.49 |
|
| 2017 |
Boyoglu-Barnum S, Todd SO, Meng J, Barnum TR, Chirkova T, Haynes LM, Jadhao SJ, Tripp RA, Oomens AG, Moore ML, Anderson LJ. Mutating the CX3C motif in the G protein should make a live respiratory syncytial virus vaccine safer and more effective. Journal of Virology. PMID 28275196 DOI: 10.1128/Jvi.02059-16 |
0.479 |
|
| 2017 |
Hwang HS, Kim KH, Lee Y, Lee YT, Ko EJ, Park S, Lee JS, Lee BC, Kwon YM, Moore ML, Kang SM. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats. Human Vaccines & Immunotherapeutics. 0. PMID 28129031 DOI: 10.1080/21645515.2016.1272743 |
0.442 |
|
| 2017 |
Lee S, Nguyen MT, Currier MG, Jenkins JB, Strobert EA, Kajon AE, Madan-Lala R, Bochkov YA, Gern JE, Roy K, Lu X, Erdman DD, Spearman P, Moore ML. Immunogenicity of 50-Valent Rhinovirus Vaccine Journal of Allergy and Clinical Immunology. 139: AB376. DOI: 10.1016/J.Jaci.2016.12.899 |
0.309 |
|
| 2016 |
Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, ... ... Moore ML, et al. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Nature Communications. 7: 13916. PMID 28000669 DOI: 10.1038/Ncomms13916 |
0.444 |
|
| 2016 |
Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK, Shankar J, Yooseph S, Nelson KE, Halpin RA, Moore ML, Anderson LJ, Peebles RS, Das SR, Hartert TV. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy. The Journal of Infectious Diseases. 214: 1924-1928. PMID 27923952 DOI: 10.1093/Infdis/Jiw456 |
0.44 |
|
| 2016 |
Cheung MB, Sampayo-Escobar V, Green R, Moore ML, Mohapatra S, Mohapatra SS. Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase. Plos One. 11: e0163709. PMID 27695127 DOI: 10.1371/Journal.Pone.0163709 |
0.429 |
|
| 2016 |
Lee S, Nguyen MT, Currier MG, Jenkins JB, Strobert EA, Kajon AE, Madan-Lala R, Bochkov YA, Gern JE, Roy K, Lu X, Erdman DD, Spearman P, Moore ML. A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques. Nature Communications. 7: 12838. PMID 27653379 DOI: 10.1038/Ncomms12838 |
0.402 |
|
| 2016 |
Rostad CA, Currier MC, Moore ML. Fluorescent and Bioluminescent Reporter Myxoviruses. Viruses. 8. PMID 27527209 DOI: 10.3390/V8080214 |
0.323 |
|
| 2016 |
Stobart CC, Hotard AL, Meng J, Moore ML. Reverse Genetics of Respiratory Syncytial Virus. Methods in Molecular Biology (Clifton, N.J.). 1442: 141-53. PMID 27464692 DOI: 10.1007/978-1-4939-3687-8_10 |
0.475 |
|
| 2016 |
Rostad CA, Stobart CC, Gilbert BE, Pickles RJ, Hotard AL, Meng J, Blanco JC, Moin SM, Graham BS, Piedra PA, Moore ML. A recombinant respiratory syncytial virus vaccine candidate attenuated by a low-fusion F protein is immunogenic and protective against challenge in cotton rats. Journal of Virology. PMID 27279612 DOI: 10.1128/Jvi.00012-16 |
0.447 |
|
| 2016 |
Schobel SA, Stucker KM, Moore ML, Anderson LJ, Larkin EK, Shankar J, Bera J, Puri V, Shilts MH, Rosas-Salazar C, Halpin RA, Fedorova N, Shrivastava S, Stockwell TB, Peebles RS, et al. Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene. Scientific Reports. 6: 26311. PMID 27212633 DOI: 10.1038/Srep26311 |
0.348 |
|
| 2016 |
Rosas-Salazar C, Shilts MH, Tovchigrechko A, Chappell JD, Larkin EK, Nelson KE, Moore ML, Anderson LJ, Das SR, Hartert TV. Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk. American Journal of Respiratory and Critical Care Medicine. 193: 1180-3. PMID 27174483 DOI: 10.1164/Rccm.201512-2350Le |
0.367 |
|
| 2016 |
Stier MT, Bloodworth MH, Toki S, Newcomb DC, Goleniewska K, Boyd KL, Quitalig M, Hotard AL, Moore ML, Hartert TV, Zhou B, McKenzie AN, Peebles RS. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. The Journal of Allergy and Clinical Immunology. PMID 27156176 DOI: 10.1016/J.Jaci.2016.01.050 |
0.439 |
|
| 2016 |
Currier MG, Lee S, Stobart CC, Hotard AL, Villenave R, Meng J, Pretto CD, Shields MD, Nguyen MT, Todd SO, Chi MH, Hammonds J, Krumm SA, Spearman P, Plemper RK, ... ... Moore ML, et al. EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression. Plos Pathogens. 12: e1005622. PMID 27152417 DOI: 10.1371/Journal.Ppat.1005622 |
0.402 |
|
| 2016 |
Human S, Moore ML. How close are we to a respiratory syncytial virus vaccine? Future Virology. 11: 749-752. DOI: 10.2217/Fvl-2016-0108 |
0.441 |
|
| 2015 |
Dyer KD, Drummond RA, Rice TA, Percopo CM, Brenner TA, Barisas DA, Karpe KA, Moore ML, Rosenberg HF. Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM). Journal of Virology. PMID 26537680 DOI: 10.1128/Jvi.02279-15 |
0.505 |
|
| 2015 |
Meng J, Hotard AL, Currier MG, Lee S, Stobart CC, Moore ML. The Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein. Journal of Virology. PMID 26468535 DOI: 10.1128/Jvi.02140-15 |
0.445 |
|
| 2015 |
Stobart CC, Moore ML. Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes. Expert Review of Vaccines. 14: 1563-72. PMID 26434947 DOI: 10.1586/14760584.2015.1095096 |
0.471 |
|
| 2015 |
Shilts MH, Rosas-Salazar C, Tovchigrechko A, Larkin EK, Torralba M, Akopov A, Halpin R, Peebles RS, Moore ML, Anderson LJ, Nelson KE, Hartert TV, Das SR. Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery. Microbial Ecology. PMID 26370110 DOI: 10.1007/S00248-015-0663-Y |
0.31 |
|
| 2015 |
Chirkova T, Lin S, Oomens AG, Gaston KA, Boyoglu-Barnum S, Meng J, Stobart CC, Cotton CU, Hartert TV, Moore ML, Ziady AG, Anderson LJ. CX3CR1 is an Important Surface Molecule for RSV Infection in Human Airway Epithelial Cells. The Journal of General Virology. PMID 26297201 DOI: 10.1099/Vir.0.000218 |
0.435 |
|
| 2015 |
Walpita P, Johns LM, Tandon R, Moore ML. Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract. Plos One. 10: e0130755. PMID 26172453 DOI: 10.1371/Journal.Pone.0130755 |
0.498 |
|
| 2015 |
Deval J, Hong J, Wang G, Taylor J, Smith LK, Fung A, Stevens SK, Liu H, Jin Z, Dyatkina N, Prhavc M, Stoycheva AD, Serebryany V, Liu J, Smith DB, ... ... Moore ML, et al. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate. Plos Pathogens. 11: e1004995. PMID 26098424 DOI: 10.1371/Journal.Ppat.1004995 |
0.335 |
|
| 2015 |
Ptaschinski C, Mukherjee S, Moore ML, Albert M, Helin K, Kunkel SL, Lukacs NW. RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo. Plos Pathogens. 11: e1004978. PMID 26083387 DOI: 10.1371/Journal.Ppat.1004978 |
0.476 |
|
| 2015 |
Larkin EK, Gebretsadik T, Moore ML, Anderson LJ, Dupont WD, Chappell JD, Minton PA, Peebles RS, Moore PE, Valet RS, Arnold DH, Rosas-Salazar C, Das SR, Polack FP, Hartert TV, et al. Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE). Bmc Pulmonary Medicine. 15: 45. PMID 26021723 DOI: 10.1186/S12890-015-0040-0 |
0.395 |
|
| 2015 |
Hotard AL, Laikhter E, Brooks K, Hartert TV, Moore ML. Functional Analysis of the 60 Nucleotide Duplication in the Respiratory Syncytial Virus Buenos Aires Strain Attachment Glycoprotein. Journal of Virology. PMID 26018171 DOI: 10.1128/Jvi.01045-15 |
0.397 |
|
| 2015 |
Boyoglu-Barnum S, Todd SO, Chirkova T, Barnum TR, Gaston KA, Haynes LM, Tripp RA, Moore ML, Anderson LJ. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology. 483: 117-125. PMID 25965801 DOI: 10.1016/J.Virol.2015.02.035 |
0.431 |
|
| 2015 |
Lee YN, Hwang HS, Kim MC, Lee YT, Lee JS, Moore ML, Kang SM. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease. Antiviral Research. 115: 1-8. PMID 25513755 DOI: 10.1016/J.Antiviral.2014.12.009 |
0.54 |
|
| 2015 |
Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. American Journal of Respiratory and Critical Care Medicine. 191: 34-44. PMID 25369458 DOI: 10.1164/Rccm.201405-0901Pp |
0.386 |
|
| 2015 |
Hotard AL, Lee S, Currier MG, Crowe JE, Sakamoto K, Newcomb DC, Peebles RS, Plemper RK, Moore ML. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. Journal of Virology. 89: 512-22. PMID 25339762 DOI: 10.1128/Jvi.02472-14 |
0.445 |
|
| 2015 |
Ko EJ, Kwon YM, Lee JS, Hwang HS, Yoo SE, Lee YN, Lee YT, Kim MC, Cho MK, Lee YR, Quan FS, Song JM, Lee S, Moore ML, Kang SM. Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 99-108. PMID 25109662 DOI: 10.1016/J.Nano.2014.07.013 |
0.497 |
|
| 2015 |
Rostad C, Stobart C, Hotard A, Meng J, Gilbert B, Piedra P, Moore M. Development of a Live-Attenuated Vaccine for Respiratory Syncytial Virus Using Codon Deoptimization of Virulence Genes and a Subgroup B Fusion Protein Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1470 |
0.422 |
|
| 2015 |
Stier MT, Toki S, Goleniewska K, Moore ML, Peebles RS. Respiratory Syncytial Virus Induces IL-13+ Group 2 Innate Lymphoid Cells Via TSLP Journal of Allergy and Clinical Immunology. 135: AB171. DOI: 10.1016/J.Jaci.2014.12.1496 |
0.39 |
|
| 2015 |
Teng M, Tran KC, Hotard AL, Moore ML. Development of a Simple, Rapid Microneutralization Test for Respiratory Syncytial Virus Subgroup B Journal of Allergy and Clinical Immunology. 135: AB103. DOI: 10.1016/J.Jaci.2014.12.1269 |
0.375 |
|
| 2014 |
Meng J, Lee S, Hotard AL, Moore ML. Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes. Mbio. 5: e01704-14. PMID 25249281 DOI: 10.1128/Mbio.01704-14 |
0.481 |
|
| 2014 |
Lee S, Quan FS, Kwon Y, Sakamoto K, Kang SM, Compans RW, Moore ML. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins. Antiviral Research. 111: 129-35. PMID 25239522 DOI: 10.1016/J.Antiviral.2014.09.005 |
0.47 |
|
| 2014 |
Patel DA, You Y, Huang G, Byers DE, Kim HJ, Agapov E, Moore ML, Peebles RS, Castro M, Sumino K, Shifren A, Brody SL, Holtzman MJ. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. The Journal of Allergy and Clinical Immunology. 134: 1402-1412.e7. PMID 25216987 DOI: 10.1016/J.Jaci.2014.07.013 |
0.41 |
|
| 2014 |
Yan D, Lee S, Thakkar VD, Luo M, Moore ML, Plemper RK. Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 111: E3441-9. PMID 25092342 DOI: 10.1073/Pnas.1405198111 |
0.431 |
|
| 2014 |
Zhou W, Goleniewska K, Zhang J, Dulek DE, Toki S, Lotz MT, Newcomb DC, Boswell MG, Polosukhin VV, Milne GL, Wu P, Moore ML, FitzGerald GA, Peebles RS. Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signaling. The Journal of Allergy and Clinical Immunology. 134: 698-705.e5. PMID 25042746 DOI: 10.1016/J.Jaci.2014.06.004 |
0.313 |
|
| 2014 |
Boyoglu-Barnum S, Chirkova T, Todd SO, Barnum TR, Gaston KA, Jorquera P, Haynes LM, Tripp RA, Moore ML, Anderson LJ. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. Journal of Virology. 88: 10569-83. PMID 24990999 DOI: 10.1128/Jvi.01503-14 |
0.41 |
|
| 2014 |
Stobart CC, Moore ML. RNA virus reverse genetics and vaccine design. Viruses. 6: 2531-50. PMID 24967693 DOI: 10.3390/V6072531 |
0.375 |
|
| 2014 |
Dulek DE, Newcomb DC, Goleniewska K, Cephus J, Zhou W, Reiss S, Toki S, Ye F, Zaynagetdinov R, Sherrill TP, Blackwell TS, Moore ML, Boyd KL, Kolls JK, Peebles RS. Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner. Infection and Immunity. 82: 3723-39. PMID 24958709 DOI: 10.1128/Iai.00035-14 |
0.343 |
|
| 2014 |
Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE, Boyd KL, Moore ML, Zhou W, Peebles RS. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge. Journal of Virology. 88: 9655-72. PMID 24920804 DOI: 10.1128/Jvi.03299-13 |
0.382 |
|
| 2014 |
Meng J, Stobart CC, Hotard AL, Moore ML. An overview of respiratory syncytial virus. Plos Pathogens. 10: e1004016. PMID 24763387 DOI: 10.1371/Journal.Ppat.1004016 |
0.404 |
|
| 2014 |
Wong TM, Boyapalle S, Sampayo V, Nguyen HD, Bedi R, Kamath SG, Moore ML, Mohapatra S, Mohapatra SS. Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology. Plos One. 9: e88764. PMID 24558422 DOI: 10.1371/Journal.Pone.0088764 |
0.397 |
|
| 2014 |
Kwon YM, Hwang HS, Lee JS, Ko EJ, Yoo SE, Kim MC, Lee YN, Kim KH, Song JM, Lee S, Moore ML, Kang SM. Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease. Antiviral Research. 104: 1-6. PMID 24462695 DOI: 10.1016/J.Antiviral.2014.01.008 |
0.478 |
|
| 2014 |
Lee S, Mittler RS, Moore ML. Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice. Journal of Immunology (Baltimore, Md. : 1950). 192: 293-9. PMID 24285837 DOI: 10.4049/Jimmunol.1300453 |
0.392 |
|
| 2014 |
Lee S, Currier MG, Hotard AL, Meng J, Pretto C, Power UF, Villenave R, Shields MD, Chi MH, Peebles RS, Moore ML. Epidermal Growth Factor Receptor (EGFR) Mediates Cell Fusion and Infectivity Of Respiratory Syncytial Virus (RSV) Journal of Allergy and Clinical Immunology. 133: AB71. DOI: 10.1016/J.Jaci.2013.12.276 |
0.381 |
|
| 2013 |
Moore ML, Stokes KL, Hartert TV. The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses. Current Opinion in Immunology. 25: 761-8. PMID 24455766 DOI: 10.1016/J.Coi.2013.09.016 |
0.689 |
|
| 2013 |
Lotz MT, Moore ML, Peebles RS. Respiratory syncytial virus and reactive airway disease. Current Topics in Microbiology and Immunology. 372: 105-18. PMID 24362686 DOI: 10.1007/978-3-642-38919-1_5 |
0.424 |
|
| 2013 |
Melero JA, Moore ML. Influence of respiratory syncytial virus strain differences on pathogenesis and immunity. Current Topics in Microbiology and Immunology. 372: 59-82. PMID 24362684 DOI: 10.1007/978-3-642-38919-1_3 |
0.416 |
|
| 2013 |
Yan D, Krumm SA, Sun A, Steinhauer DA, Luo M, Moore ML, Plemper RK. Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response. Journal of Virology. 87: 11076-87. PMID 23926334 DOI: 10.1128/Jvi.01425-13 |
0.374 |
|
| 2013 |
Baviskar PS, Hotard AL, Moore ML, Oomens AG. The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism. Journal of Virology. 87: 10730-41. PMID 23903836 DOI: 10.1128/Jvi.03086-12 |
0.334 |
|
| 2013 |
Boyoglu-Barnum S, Gaston KA, Todd SO, Boyoglu C, Chirkova T, Barnum TR, Jorquera P, Haynes LM, Tripp RA, Moore ML, Anderson LJ. A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. Journal of Virology. 87: 10955-67. PMID 23885067 DOI: 10.1128/Jvi.01164-13 |
0.498 |
|
| 2013 |
Stokes KL, Currier MG, Sakamoto K, Lee S, Collins PL, Plemper RK, Moore ML. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. Journal of Virology. 87: 10070-82. PMID 23843644 DOI: 10.1128/Jvi.01347-13 |
0.693 |
|
| 2013 |
Numata M, Nagashima Y, Moore ML, Berry KZ, Chan M, Kandasamy P, Peebles RS, Murphy RC, Voelker DR. Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection. Journal of Lipid Research. 54: 2133-43. PMID 23749985 DOI: 10.1194/Jlr.M037077 |
0.477 |
|
| 2013 |
Toki S, Reiss S, Goleniewska K, Moore ML, FitzGerald G, Peebles RS. Prostaglandin I2 Receptor (IP) Signaling Inhibits Lung Type I Interferon Expression by RSV Infection Journal of Allergy and Clinical Immunology. 131: AB191. DOI: 10.1016/J.Jaci.2012.12.1348 |
0.335 |
|
| 2012 |
Hotard AL, Shaikh FY, Lee S, Yan D, Teng MN, Plemper RK, Crowe JE, Moore ML. A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology. 434: 129-36. PMID 23062737 DOI: 10.1016/J.Virol.2012.09.022 |
0.393 |
|
| 2012 |
Cherukuri A, Stokes KL, Patton K, Kuo H, Sakamoto K, Lambert S, Stillman E, Moore ML, Lee S. An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice. Immunity & Ageing : I & A. 9: 21. PMID 23031690 DOI: 10.1186/1742-4933-9-21 |
0.684 |
|
| 2012 |
Lee S, Stokes KL, Currier MG, Sakamoto K, Lukacs NW, Celis E, Moore ML. Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice. Journal of Virology. 86: 13016-24. PMID 23015695 DOI: 10.1128/Jvi.01770-12 |
0.653 |
|
| 2012 |
Krishnamoorthy N, Khare A, Oriss TB, Raundhal M, Morse C, Yarlagadda M, Wenzel SE, Moore ML, Peebles RS, Ray A, Ray P. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nature Medicine. 18: 1525-30. PMID 22961107 DOI: 10.1038/Nm.2896 |
0.435 |
|
| 2011 |
Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. The Journal of Infectious Diseases. 204: 987-95. PMID 21881112 DOI: 10.1093/Infdis/Jir474 |
0.451 |
|
| 2011 |
Stokes KL, Chi MH, Sakamoto K, Newcomb DC, Currier MG, Huckabee MM, Lee S, Goleniewska K, Pretto C, Williams JV, Hotard A, Sherrill TP, Peebles RS, Moore ML. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. Journal of Virology. 85: 5782-93. PMID 21471228 DOI: 10.1128/Jvi.01693-10 |
0.677 |
|
| 2011 |
Sloan C, Moore ML, Hartert T. Impact of pollution, climate, and sociodemographic factors on spatiotemporal dynamics of seasonal respiratory viruses. Clinical and Translational Science. 4: 48-54. PMID 21348956 DOI: 10.1111/J.1752-8062.2010.00257.X |
0.387 |
|
| 2011 |
Chi HM, Moore ML, Peebles RS. The intersection of respiratory syncytial virus infection, innate immunity and allergic lung disease Allergens and Respiratory Pollutants: the Role of Innate Immunity. 229-243. DOI: 10.1016/B978-1-907568-54-1.50011-0 |
0.349 |
|
| 2009 |
Moore ML, Newcomb DC, Parekh VV, Van Kaer L, Collins RD, Zhou W, Goleniewska K, Chi MH, Mitchell D, Boyce JA, Durbin JE, Sturkie C, Peebles RS. STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection. Journal of Immunology (Baltimore, Md. : 1950). 183: 2016-26. PMID 19587017 DOI: 10.4049/Jimmunol.0803167 |
0.412 |
|
| 2009 |
Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, Newcomb DC, Buchholz UJ, Crowe JE, Goleniewska K, Williams JV, Collins PL, Peebles RS. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. Journal of Virology. 83: 4185-94. PMID 19211758 DOI: 10.1128/Jvi.01853-08 |
0.448 |
|
| 2008 |
Zhou W, Newcomb DC, Moore ML, Goleniewska K, O'Neal JF, Peebles RS. Cyclooxygenase inhibition during allergic sensitization increases STAT6-independent primary and memory Th2 responses. Journal of Immunology (Baltimore, Md. : 1950). 181: 5360-7. PMID 18832692 DOI: 10.4049/Jimmunol.181.8.5360 |
0.321 |
|
| 2008 |
Moore ML, Chi MH, Goleniewska K, Durbin JE, Peebles RS. Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection. Viral Immunology. 21: 327-39. PMID 18788941 DOI: 10.1089/Vim.2008.0003 |
0.43 |
|
| 2008 |
NEWCOMB D, MOORE M, GOLENIEWSKA K, ZHOU W, PEEBLESJR R. Respiratory Syncytial Virus Infections Augment Allergen-Specific T Cell Secretion of Lung IL-17A Journal of Allergy and Clinical Immunology. 121: S135-S135. DOI: 10.1016/J.Jaci.2007.12.540 |
0.436 |
|
| 2008 |
MOORE M, CHI M, WILLIAMS J, WRIGHT P, CROWEJR J, EDWARDS K, POLOSUKHIN V, GOLENIEWSKA K, PEEBLESJR R. A Clinical Isolate Strain of Respiratory Syncytial Virus (RSV) Causes Airway Obstruction and Histopathology in Mice Similar to Severe RSV Disease in Infants Journal of Allergy and Clinical Immunology. 121: S268-S268. DOI: 10.1016/J.Jaci.2007.12.1063 |
0.33 |
|
| 2007 |
Moore ML, Chi MH, Zhou W, Goleniewska K, O'Neal JF, Higginbotham JN, Peebles RS. Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity. Journal of Immunology (Baltimore, Md. : 1950). 178: 2651-4. PMID 17312105 DOI: 10.4049/Jimmunol.178.5.2651 |
0.461 |
|
| 2007 |
Moore M, Parekh V, Van Kaer L, Collins R, Goleniewska K, O'Neal J, Chi M, Durbin J, Peebles R. Natural Killer (NK) Cells, Not T Cells, Produce the Cytokine IL-4 in Response to Primary Respiratory Syncytial Virus Infection Journal of Allergy and Clinical Immunology. 119: 523. DOI: 10.1016/J.Jaci.2006.12.626 |
0.403 |
|
| 2006 |
Lukacs NW, Moore ML, Rudd BD, Berlin AA, Collins RD, Olson SJ, Ho SB, Peebles RS. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. The American Journal of Pathology. 169: 977-86. PMID 16936271 DOI: 10.2353/Ajpath.2006.051055 |
0.425 |
|
| 2006 |
Moore ML, Peebles RS. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacology & Therapeutics. 112: 405-24. PMID 16820210 DOI: 10.1016/J.Pharmthera.2006.04.008 |
0.48 |
|
| 2006 |
Moore M, Lukacs N, Rudd B, Polosukhin V, Chi M, Goleniewska K, O'Neal J, Peebles R. Respiratory Syncytial Virus-Induced Airway Dysfunction Depends on the Virus Strain Journal of Allergy and Clinical Immunology. 117: S206. DOI: 10.1016/J.Jaci.2005.12.814 |
0.437 |
|
| 2005 |
Peebles RS, Hashimoto K, Sheller JR, Moore ML, Morrow JD, Ji S, Elias JA, Goleniewska K, O'neal J, Mitchell DB, Graham BS, Zhou W. Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent. Journal of Immunology (Baltimore, Md. : 1950). 175: 8253-9. PMID 16339565 DOI: 10.1016/J.Jaci.2005.12.580 |
0.33 |
|
| Show low-probability matches. |